Stevanato Group (NYSE:STVN) Stock Price Up 5.5% - Time to Buy?

Key Points

• Stevanato shares rose 5.5% to €14.67, though trading volume was 54% below its average.
• The company reported quarterly EPS of €0.16, missing the €0.17 consensus estimate; revenue was €326.06 million.
• Analysts’ consensus rating is Moderate Buy, with mixed recent actions: Citigroup and UBS cut price targets, while a director bought 25,000 shares.

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) shares were up 5.5% during trading on Thursday. The company traded as high as €14.65 and last traded at €14.67. 259,294 shares changed hands during trading, a decline of 54% from the average session volume of 560,264 shares. The stock had previously closed at €13.91.

Analyst Ratings Changes

STVN has been the topic of several research analyst reports. Weiss Ratings raised Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 27th. Citigroup decreased their price target on shares of Stevanato Group from $26.00 to $20.00 and set a "buy" rating for the company in a research note on Wednesday, November 4th. William Blair downgraded shares of Stevanato Group from an "outperform" rating to a "market perform" rating in a research report on Wednesday, November 4th. Deutsche Bank began coverage on shares of Stevanato Group in a research note on Wednesday, October 7th. They issued a "hold" rating on the stock. Finally, UBS Group reduced their target price on shares of Stevanato Group from $23.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, November 4th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy".

Stevanato Group Trading Up 4.3%

The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.19 and a current ratio of 1.73. The stock has a market capitalization of $4.39 billion, a PE ratio of 25.06, a price-to-earnings-growth ratio of 1.40 and a beta of 0.80. The business's 50-day moving average is €19.36 and its two-hundred day moving average is €17.93.

Stevanato Group (NYSE:STVN - Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported €0.16 EPS for the quarter, missing the consensus estimate of €0.17 by (€0.01). Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%. The firm had revenue of €326.06 million during the quarter. As a group, equities research analysts anticipate that Stevanato Group S.p.A. will post 0.67 earnings per share for the current year.

Insider Activity at Stevanato Group

In other Stevanato Group news, Director Donald E. Morel, Jr. acquired 25,000 shares of the business's stock in a transaction on Friday, November 6th. The stock was purchased at an average price of €13.07 per share, for a total transaction of €326,750.00. Following the completion of the transaction, the director owned 62,424 shares of the company's stock, valued at €815,881.68. The trade was a 66.80% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mauro Stocchi sold 13,649 shares of the firm's stock in a transaction on Monday, September 28th. The shares were sold at an average price of €21.50, for a total value of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares of the company's stock, valued at approximately €8,600,000. This trade represents a 3.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. First Bank & Trust increased its holdings in Stevanato Group by 3.4% in the second quarter. First Bank & Trust now owns 18,417 shares of the company's stock valued at $333,000 after buying an additional 603 shares in the last quarter. Fifth Third Bancorp grew its holdings in Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company's stock valued at $58,000 after purchasing an additional 773 shares during the last quarter. PineStone Asset Management Inc. grew its holdings in Stevanato Group by 8.4% in the third quarter. PineStone Asset Management Inc. now owns 41,335 shares of the company's stock valued at $867,000 after purchasing an additional 3,200 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new stake in Stevanato Group in the second quarter valued at $59,000. Finally, GW&K Investment Management LLC increased its position in shares of Stevanato Group by 118.3% in the third quarter. GW&K Investment Management LLC now owns 6,086 shares of the company's stock valued at $128,000 after buying an additional 3,298 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.